TG Therapeutics Inc. (TGTX) Next Earnings Date & Options-Implied ±6.5% Move
TG Therapeutics Inc. (TGTX) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (60/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (+181.1% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
Options-Implied Post-Earnings ±6.5% Bell Curve
Will TGTX Beat & Rip or Miss Next Quarter?
Trailing EPS: $2.92 • YoY Revenue Growth: 87.3%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $616.3M | $447.2M | -$25.0M | 83.7% |
| FY 2024 | 2024-12-31 | $329.0M | $23.4M | -$40.6M | 88.3% |
| FY 2023 | 2023-12-31 | $233.7M | $12.7M | -$41.9M | 44% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring TGTX)
- ✓Live walkthrough of TGTX's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
TGTX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +87.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on TGTX today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for TGTX. Explore sector supply chains on /butterfly.
TGTX Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is TGTX's next earnings date?
Based on SEC filing cadence, TG Therapeutics Inc. (TGTX)'s next quarterly earnings window is estimated around Dec 30, 2026.
How much is TGTX stock expected to move on earnings?
Options markets currently imply a ±6.5% post-earnings move for TGTX, projecting a trading range between $54.3 and $61.86.